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SAXDThe structure and membrane interactions of three antimicrobial peptides from the lactoferrin family were in-
vestigated through different techniques. Circular dichroism shows that the peptides adopt a secondary struc-
ture in the presence of DMPC/DMPG, and DSC reveals that they all interact with these membranes, albeit
differently, whereas only LFchimera has an effect in pure zwitterionic membranes of DMPC. DSC further
shows that membrane action is weakest for LFcin17-30, increases for LFampin265-284 and is largest for
LFchimera. These differences are clearly reﬂected in a different structure upon interaction, as revealed by
SAX. This technique shows that LFcin17-30 only induces membrane segregation (two lamellar phases are ap-
parent upon cooling from ﬂuid phase), whereas LFampin265-284 induces micellization of the membrane
with structure compatible to a micellar cubic phase of space group Pm3n, and LFchimera leads to membrane
destruction through the formation of two cubic phases, Pn3m and Im3m. These structural results show a re-
markable parallel with the ones obtained previously by freeze fracture microscopy of the effect of these pep-
tides against Candida albicans.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
We continue to face a reemergence of infectious diseases, mainly
due to the increasing resistance of the pathogens to current therapies
and the lack of new and more effective antimicrobial drugs. One po-
tential and interesting alternative to conventional antibiotics is the
use of antimicrobial peptides (AMPs). Natural AMPs are present in
almost all living organisms as a primary defense mechanism against
invading pathogens, with remarkably different structures and bioac-
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rights reserved.AMPs are considered membrane-active agents leading to cell
death by acting on the phospholipid membrane [2]. Within this
broad umbrella, it is recognized today that they do not act through
a universal mechanism. Different mechanisms have been proposed,
consistent with experimental results, providing possible ways for
the peptides to disrupt the membrane, leading to cell death. All rely
on the same main factor for initial action — adsorption of AMPs onto
the membrane due to electrostatic interactions between the cationic
peptides and the headgroups of anionic phospholipids. Thereafter,
accumulation and positional change eventually lead to the formation
of pores, membrane permeabilization or membrane micellization
[1,3–7]. In some cases internal targets have also been described
[5,8–11].
Independently of the details of themechanism of action the interac-
tion must be as selective as possible regarding the distinction between
mammalian cells (higher eukaryotes) and pathogen cells, such as bacte-
ria (prokaryotic cells) or lower eukaryotes as fungi and protozoan.
Cytoplasmic membranes of mammalian cells expose predominantly
zwitterionic phosphatidylcholine (PC) and sphingomyelin to the extra-
cellular side [1]. On the other hand, cytoplasmic bacterial membranes
are mainly composed of zwitterionic phosphatidylethanolamine (PE)
and negatively charged phosphatidylglycerol (PG) conferring an overall
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fungi and protozoa also have PC, but they have higher amounts of ex-
posed anionic phospholipids, like phosphatidylserine, thanmammalian
cells [1,13,14]. Indeed it is this differential composition that justiﬁes the
unifying electrostatic character of the initial interaction, as well as the
ability of the AMPs to act preferentially against pathogens.
Biophysical studies can provide important information on the de-
tails of AMPs interaction with the membranes and thus help to unrav-
el their mechanism of action, by providing insight into the effects of
the peptides on the membrane structure and information on peptide
location. Different techniques have been employed, such as calorime-
try, spectroscopy, X-ray diffraction and others [3,12,15–28].
X-ray diffraction studies can give quantitative information on the
effects of AMPs on membrane structure, namely if they are capable
of altering the phospholipid structure and organization, as well as
phase behavior. This information thus allows correlation of these pos-
sible changes in lipid polymorphism with models for the mechanism
of action of AMPs [12,22,23,28]. Growing evidence shows that lipid
cubic phases are ubiquitous in the biological world as they have
been detected in the plasma membrane of archaebacteria, as well as
in the endoplasmic reticulum and mitochondria of mammalian cells.
These phases are also involved in biological processes such as mem-
brane fusion, fat digestion and in the reorganization of cell membrane
composition [1,29–32]. In the AMP research area, some reports
started to appear in the literature indicating the ability of AMPs to in-
duce cubic phases. So far most studies have revealed the existence of
bicontinuous (single or double) cubic phases [12,19,24–28,33–35]
and a recent one reported a micellar cubic phase [36].
Previously, Bolscher et al. [37,38] have obtained freeze-fracture
results on the action of peptides of the lactoferrin family against Can-
dida albicans, showing that the peptides have a quite different effect
on the membrane of this pathogen. In the present work we studied
the action of these peptides on model membranes of DMPC/DMPG
(3:1), considered to be a good model system for C. albicans, by a vari-
ety of biophysical techniques. We found that lactoferricin 17–30
(LFcin17-30) induces phase segregation and is the peptide with low-
est membrane activity, lactoferrampin 265–284 (LFampin265-284)
induces a micellar cubic phase (Pm3n) [36], which to the best of
our knowledge is the ﬁrst experimental evidence of such phase in
the context of antimicrobial peptide/membrane interaction. Finally
LFchimera, a hybrid peptide between the ﬁrst two [16], induces two
cubic phases of Pn3m and Im3m symmetry. These results parallel
their effect on C. albicans as derived from freeze-fracture electron mi-
croscopy, indicating a remarkable agreement between simple model
systems and living organisms.
2. Materials and methods
2.1. Peptide synthesis, puriﬁcation and characterization
LFcin17-30, LFampin265-284 and LFchimera were synthesized by
solid phase peptide synthesis using Fmoc-protected amino acids
(Orpegen Pharma GmbH, Heidelberg, Germany) in a Syro II synthe-
sizer (Biotage, Uppsala Sweden) as described previously [16]. The
chimerical peptide comprises a single C-terminal amidated lysine
substituted at the α- and ε-amino groups with the two peptides via
the C-terminal site and leaving two N-termini as free ends. Peptides
were puriﬁed to a purity of at least 95% by semipreparative RP-HPLC
(Jasco Corporation Tokyo, Japan) on a Vydac C18-column (218MS510;
Vydac, Hesperia, CA, USA) and the authenticity of the peptides was con-
ﬁrmed byMALDI-TOFmass spectrometry on aMicroﬂex LRFmass spec-
trometer equipped with an additional gridless reﬂectron (Bruker
Daltonik, Bremen, Germany) as described previously [39]. In Table 1
we provide basic information of the peptides, together with their LC50
and their ultrastructural effects against C. albicans, as obtained previ-
ously by Bolscher et al. [37,38].2.2. Preparation of liposomes
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC)was dissolved
in chloroform, and its mixture with 1,2-dimyristoyl-sn-glycero-3-
[phospho-rac-(1-glycerol)] (DMPG) at amolar ratio of 3:1was dissolved
in chloroform/methanol (3:1 (v/v)). Both lipids were from Avanti Polar
Lipids, Alabama, USA. A ﬁlm was prepared thereafter in round bottom
ﬂasks by drying the sample under a stream of nitrogen, and was kept
under vacuum for 3 h to remove all traces of organic solvents. After dry-
ing, the lipid ﬁlm was ﬁrst warmed for 30 min at ca. 10 °C above the
temperature of the gel-to-liquid crystalline phase transition (Tm) in a
thermostated water bath, and afterwards hydrated with buffer, either
HEPES (10 mM HEPES, 100 mM NaCl, pH 7.4) or PBS (9.3 mM,
154 mMNaCl, pH 7.2), kept at the same temperature. Themultilamellar
vesicles (MLVs) were obtained by alternating gentle vortex with short
periods in the thermostated water bath at ~35 °C. After this the MLVs
were frozen in liquid nitrogen and thawed in a water bath at 35 °C,
and this process was repeated 5 times.
Large unilamellar vesicles (LUVs) were obtained from the MLVs by
extrusion in a 10 ml stainless steel extruder (Lipex Biomembranes,
Vancouver, BC, Canada), inserted in a thermostated cell with a
re-circulating water bath, at 35 °C. The samples were passed several
times through polycarbonate ﬁlters (Nucleopore, Pleasanton, CA,
USA) of decreasing pore size (600, 200 and 100 nm; 5, 5 and 10
times, respectively), under inert (N2) atmosphere.
Size distribution of extruded vesicles was determined by qels anal-
ysis (Malvern Zeta Sizer 5000, Malvern Instruments, Malvern,
Worcestershire,UK) using a helium-neon laser (633 nm) as a source
of incident light, and operating at a scattering angle of 90° and at
37 °C. Mean particle size was thus determined as being of 106±4 nm
(average and standard deviation of 6 independent measurements). The
phospholipid concentration was determined by the phosphomolibdate
method [40].2.3. Differential scanning calorimetry
Differential scanning calorimetry (DSC) was performed in a
Micro-DSCIII microcalorimeter (SETARAM, Caluire, France) essentially
as described previously [41]. In brief, samples were run against HEPES
buffer in the reference cell, and blank experiments with HEPES buffer
in both cells were also performed for subsequent blank correction.
The solution or suspension volume used in each cell was of around
0.8 ml, and the masses of solution in sample and reference cells were
subsequently matched by weighing ±0.00005 g. Two successive
heating and cooling scans were performed for each sample, the heating
scan at a scanning rate of 0.5 °C/min and the cooling scan at 3 °C/min,
over the temperature range of 10–35 °C. The results provided here al-
ways refer to the second heating scan, as we have observed that
small differences can exist between ﬁrst and second scans, but not
thereafter. The sample mixtures were prepared immediately before
the DSC run, by adding the desired amount of peptide (LFcin17-30,
LFampin265–284 or LFchimera) stock solution (in HEPES buffer)
to the LUVs suspension of DMPC or DMPC/DMPG (3:1). Samples
with peptide-to-lipid molar ratios (P:L) from 1:197 to 1:29 were
used. All procedures regarding sample preparation and handling
(lag time at low temperature, time between mixtures, and start of
the experiment) were kept constant in all experiments, to ensure
that all samples had the same thermal history. The instrument was
electrically calibrated for temperature and the scan rate with the
SETARAM Calibration Unit. The Micro-DSCIII software was used for
blank subtraction (run with buffer solution on both cells (sample
and reference)). Tm and the ΔtransH were calculated by integration
of the heat capacity versus temperature curve (Cp versus Temperature).
A linear baseline was used to calculate the integral areas under the
curves [41].
Table 1
Properties of synthetic lactoferrin peptides.
Peptide LFcin17-30 LFampin265-284 LFchimeraa
Sequence FKCRRWQWRMKKLG DLIWKLLSKAQEKFGKNKSR FKCRRWQWRMKKLG–K DLIWKLLSKAQEKFGKNKSR
Chargeb +6 +4 +12
Freeze fracture microscopyc
LC50d 1.5 1.2 0.5
a The carboxyl group of the linking lysine (C-terminal) is in carboxamide form.
b Calculated overall charge at pH=7.0.
c From previously published results [37,38]. Insert (a) is the control. The scale is embedded in each ﬁgure.
d From previously published results [37,38]; LC50 is the peptide lethal concentration that causes 50% of C. albicans death determined in a 5 mM NaCl containing phosphate buffer.
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Circular dichroism (CD) experiments were carried out in a Jasco
720 spectropolarimeter (Japan Spectroscopy Co., Tokyo) equipped
with a rectangular cell, path length of 1 mm. Scans were performed
between 175 and 250 nm, bandwidth 1.0 nm, and resolution of
100 mdeg. The measurements were performed in 2 mM HEPES,
100 mM NaCl, pH 7.4. Spectra of pure liposome preparations were
performed in the same solvent media at the concentrations used in li-
posome/peptide mixture. These were used as blank experiments to
be subtracted from the liposome/peptide spectra. The peptide con-
centration in buffer was 36 μM. Liposome concentrations were:
6 mM for DMPC and 3 mM for DMPC/DMPG (3:1), in both cases
with a P:L ratio of 1:167. The peptide solution and liposome suspen-
sion were mixed just prior to each measurement and incubated at
35 °C for 30 min and measurements were performed thereafter
at the same temperature. Each spectrum was the average of nine ac-
cumulations. After blank correction, the observed ellipticity was
converted to a mean residue molar ellipticity (θ) (deg·cm2·dmol−1),
based on the total amount of peptide in the mixture.
2.5. X-ray diffraction studies
Peptide solution in the same buffer used for preparing the lipo-
somes was added to the liposome suspension at different P:L molar
ratios, and the mixtures were incubated for 30 min at 35 °C. The sam-
ples were then centrifuged at 13 000 rpm in a microcentrifuge at
least for 15 min, and transferred thereafter into glass capillaries
(Spezialglas Markröhrchen 1.5 mm capillaries, Glass Technik &
Konstruktion — Müller & Müller OHG, Germany). In the transfer
care was taken to always have a signiﬁcant amount of supernatant
in the capillaries, to guarantee that all samples were studied at high
water contents. The capillaries were sealed by ﬂame, and stored at
4 °C, at least 3 days before use.
Small angle X-ray diffraction (SAXD) and wide angle X-ray diffrac-
tion (WAXD) experiments were performed at the synchrotron soft con-
densed matter beamline A2 in HASYLAB at Deutsches Elektronen
Synchrotron (DESY), Hamburg, Germany, using a monochromatic radi-
ation ofλ=0.15 nmwavelength. Diffractogramswere taken at selected
temperatures, where the sample was equilibrated for 5 min before ex-
posure to radiation, or by performing up and down temperature scans
at a scan rate 1 °C/min, where diffractograms were recorded for 10 s
every minute. The heating and cooling of the sample were regulated
by a thermocouple connected to the temperature controller JUMOIMAGO 500 (JUMO GmbH & Co. KG, Fulda, Germany). The evacuated
double-focusing camera was equipped with a linear position sensitive
detector for WAXD and a 2D MarCCD detector or a linear position sen-
sitive detector for SAXD. The raw data were normalized against the in-
cident beam intensity. The SAXD patterns were calibrated using Ag
behenate [42] or rat tail collagen [43] and the WAXD patterns by
tripalmitin or polyethylene terephthalate [44,45]. Each diffraction
peak was ﬁtted by Lorentzians above a linear background by use of
the Peakﬁt or Origin software programs, in order to derive the lattice
parameters. For cubic phases, the lattice parameter was determined as
the slope of the dependence of s(Å−1) vs. √(h2+k2+ l2), passing
through the origin (0,0), where h, k, l are Miller indices. The uncertainty
assigned to the lattice parameters is half of the interval of maximum
width that can be obtained through calculation of minimum and maxi-
mum values for lattice parameters from the slope above together with
its statistical standard error, as obtained from the regression. For lamel-
lar phases, the obtained uncertainty never exceeds ±0.1 Å, and thus
from hereafter we will not quote the uncertainty for the lattice param-
eter in lamellar phases. The reported uncertainties for cubic phase lat-
tice parameters are calculated as above and presented together with
the lattice parameter value throughout the text.
3. Results
3.1. Differential scanning calorimetry
DSC experiments show the inﬂuence of both lipid charge and
peptide-to-lipid molar ratio (P:L) on the thermotropic behavior of
the peptide/lipid systems. The endotherms obtained for each peptide,
LFcin17-30, LFampin265-284 and LFchimera, with the model mem-
branes of DMPC and DMPC/DMPG (3:1), are shown in Figs. 1 and 2,
respectively.
The thermodynamic description is based on the parameters
characterizing the gel-to-liquid crystalline phase transition of the
liposomes, namely transition temperature (Tm) and the correspond-
ing enthalpy change (ΔH). By comparing the calorimetric proﬁles
obtained for the pure liposomes and the liposome/peptide mixtures
at the various P:L ratios allow us to derive the inﬂuence of the pep-
tides on this thermotropic transition. The obtained thermodynamic
parameters are listed in Tables 2 and 3, where values for the pure
lipid systems are also shown. In order to overcome the slight differ-
ences that may occur for different lipid samples, measurements of
the same peptide/lipid system were always performed with liposome
suspension from the same preparation batch.
Fig. 1. DSC curves for DMPCandDMPC/peptidemixtures of varying composition. The lipid
concentration was 3.0±0.3 mM in all experiments. (a) LFcin17-30; (b) LFampin265-284
and (c) LFchimera. Pure lipid (solid black); P:L=1:196 (solid gray); P:L=1:129 (solid
light gray); P:L=1:96 (dash black); P:L=1:46 (dash gray); P:L=1:29 (dash light gray).
Maximal P:L molar ratio used was 1:46 for LFchimera.
Fig. 2. DSC curves for DMPC/DMPG (3:1) and DMPC/DMPG (3:1)/peptide mixtures
of varying composition. The lipid concentration was 3.0±0.3 mM in all experiments.
(a) LFcin17-30; (b) LFampin265-284 and (c) LFchimera. Pure lipid (solid black); P:L=
1:196 (solid gray); P:L=1:129 (solid light gray); P:L=1:96 (dash black); P:L=1:46
(dash gray); P:L=1:29 (dash light gray). Maximal P:L molar ratio used was 1:46 for
LFchimera.
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ized by a temperature of 24.5 °C and an enthalpy change that varies be-
tween 19 and 27 kJ·mol−1 (Table 2) for different sample preparations.
The ΔHtrans value observed for the sample used together with
LFchimera is signiﬁcantly higher than the other two (stated uncertainty
between samples ±3 kJ·mol−1), but the same sample was used for all
mixtures with this peptide, and the results are consistent within
sample. The observed thermodynamic parameters are in very good
agreement with literature values [41,46,47]. The calorimetric proﬁle
for the pure lipid system is a symmetric and cooperative peak. As re-
garding the peptide/lipid mixtures, we can see that LFcin17-30 and
LFampin265-284 do not alter the gel-to-liquid crystalline transition, asthe curves are superimposable for all tested P:L ratios and the parame-
ters Tm and ΔHtrans are the same, within the stated uncertainty (Fig. 1a
and b, and Table 2). As for LFchimera, it is clear that this peptide inter-
acts with the zwitterionic lipid system for all P:L ratios, and as a result
we observe a progressive decrease of Tm as the peptide content in the
mixture increases, reﬂecting a better interactionwith the liquid crystal-
line phase, and the appearance of a shoulder at the high temperature
side for the highest P:L ratios (Fig. 1c and Table 2), which is indicative
of domain segregation in the membrane [41]. The ΔHtrans values
decrease with increasing peptide content, indicating a progressive
Table 2
Thermodynamic parameters Tm and ΔHtrans for the gel to liquid crystalline phase transition of DMPC liposomes for different P:L ratios.
Tm
a (°C) ΔH transb (kJ mol−1)
(P:L) LFcin17-30 LFampin265-284 LFchimera LFcin17-30 LFampin265-284 LFchimerac
0 24.4 24.5 24.4 22 19 27
1:196 24.4 24.5 23.7 21 21 26
1:129 24.4 24.5 23.6 22 21 23
1:96 24.4 24.5 23.5 20 19 23
1:46 24.3 24.5 23.3 20 18 23
1:29 24.3 24.4 – 21 18 –
a Tm estimated uncertainty is ±0.1 °C (same liposomes preparation, used for the full P:L series) and ±0.3 °C (within samples).
b ΔHtrans estimated uncertainty is ±0.5 kJ mol−1 (same liposomes preparation, used for the full P:L series) and ±3 kJ mol−1 (within samples).
c The value for pure lipid is signiﬁcantly higher than for the other peptides, but is consistent within the same preparation (series) for this peptide.
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deeper insertion of the peptide in the hydrocarbon moiety.
As regarding the mixed system DMPC/DMPG (3:1), we can see
that an interaction exists for the three peptides, with strength that in-
creases in the order LFcin17-30, LFampin265-284 and LFchimera
(Fig. 2). This is reﬂected in a very small change in the thermodynamic
parameters for LFcin17-30 that is higher for LFampin265–284, and
much more signiﬁcant for LFchimera. In all cases we observe a de-
crease in Tm and ΔHtrans (Table 3). For LFcin17-30, although the de-
crease in both parameters is within the quoted uncertainty, the
observed trend is clearly downwards (Fig. 2a). For LFampin265-284
the differences are already outside the error limits at the highest P:L
ratios, and overall the trend in both parameters is towards lower
values. It should be stressed that for this peptide a signiﬁcant change
in shape occurs already at P:L ratio 1:46, as a very distorted curve
with signiﬁcantly higher width is observed, showing a large reduction
in the cooperativity of the transition. This indicates the onset of a sig-
niﬁcant structural change in the membrane at higher P:L ratios
(Fig. 2b).
For LFchimera the decrease in both parameters is signiﬁcant for all
P:L ratios, and although overall the shape of the calorimetric proﬁle is
somewhat similar to the one observed for DMPC, it is clear that the ef-
fect is much stronger (Fig. 2c). Again we see a trend for Tm and ΔHtrans
to decrease as peptide content in the mixtures increases. This is rea-
sonable, as on one hand the system is still predominantly zwitterionic
(DMPC is 75% of the lipid content of the membrane), and on the other
the electrostatic favorable contribution in the case of the partially
negatively charged system DMPC/DMPG (3:1) is expected to increase
the interaction, as seen in the results. Further, the proﬁle is sig-
niﬁcantly different from the ones observed for the constituent pep-
tides. We observed the same differential pattern in DSC studies of
the three peptides with DMPG liposomes, where LFchimera had a
completely disruptive behavior already at low P:L ratios, at odds
with the other two peptides, that only presented a signiﬁcant interac-
tion as the P:L ratio increases [16]. This was also seen by Haney et al.
in a DSC study with DPPG liposomes [18]. Again these results are in
line with the effect that these peptides show on C. albicans, as it will
be discussed further.Table 3
Thermodynamic parameters Tm and ΔHtrans for the gel to liquid crystalline phase transition
Tm
a (°C)
(P:L) LFcin17-30 LFampin265-284 LFchimera
0 25.0 25.0 24.8
1:196 25.0 24.9 24.7
1:129 25.0 24.9 24.5
1:96 25.0 24.8 23.7
1:46 24.8 24.4 23.2
1:29 24.6 23.9 –
a Tm estimated uncertainty is ±0.1 °C (same liposomes preparation, used for the full P:L
b ΔHtrans estimated uncertainty is ±0.5 kJ mol−1 (same liposomes preparation, used forFinally in order to try to shed some light in the observed lipid/peptide
cubic organization for the mixture DMPC/DMPG (3:1) and LFampin265-
284 at high peptide contents [36] we did perform some further DSC ex-
periments at higher P:L ratios for this system, and the obtained results
can be seen in Fig. 3. A clear peak splitting is observed, as anticipated in
the highest ratio of previous collection of results. Overall the transitions
occur between 20 and 30 °C, and when we did the deconvolution of
the overall DSC curves, two peaks were obtained, one at lower and the
other at higher temperature as compared to the pure lipid mixture.
At 1:12 the ﬁrst transition is about one degree higher than the ones
observed for 1:8 and 1:3, whereas the higher temperature transition
occurs at about the same temperature (within estimated uncertainty)
irrespective of P:L ratio.
3.2. Circular dichroism
The secondary structures of LFcin17-30, LFampin265-284 and
LFchimera were examined by CD in HEPES buffer and in the presence
of the liposome systems. CD spectra of the peptides at a concentration
of 36 μM in the aqueous buffer (2 mM HEPES, 100 mM NaCl, pH=
7.4) are shown in Fig. 4, together with the CD spectra obtained in
the presence of DMPC and DMPC/DMPG (3:1) liposomes. Measure-
ments at different peptide concentrations in aqueous buffer showed
that the peptide structures are not signiﬁcantly affected by peptide
concentration within the concentration range of 15 to 50 μM (results
not shown). Therefore, only one concentration is plotted for each
peptide in buffer. As for peptide/liposome mixtures, we have tested
several combinations, and observed that all provide the same second-
ary structure information. Therefore, we only plot the ones that pro-
vided the best quality spectra.
All peptides show a predominantly random coil structure in buffer.
In the presence of DMPC the structure remains practically the same
for LFampin265-284, whereas LFcin17-30 changes slightly the minima
to higher wavelengths and more negative ellipticity values between
210 and 230 nm, indicating a more signiﬁcant contribution of
β-structure to the overall CD signal (Fig. 4a and b). In the case of
LFchimera, we have a mixture of structures, where the minimum
around 200 nmmoves to about 217 nm, characteristic of the presenceof DMPC/DMPG (3:1) liposomes for different P:L ratios.
ΔH transb (kJ mol−1)
LFcin17-30 LFampin265-284 LFchimera
23 21 26
22 21 26
22 19 24
22 19 21
22 20 20
21 18 –
series) and ±0.3 °C (within samples).
the full P:L series) and ±3 kJ mol−1 (within samples).
Fig. 3. DSC curves for DMPC/DMPG (3:1) and DMPC/DMPG (3:1)/LFampin 265–284
mixtures at high P:L ratios. The lipid concentration was 6.0±0.3 mM in all experi-
ments. Pure lipid (solid black); P:L=1:12 (heavy solid black); P:L=1:8 (heavy solid
gray); P:L=1:3 (heavy solid light gray). The dashed (low temperature peak) and dot-
ted (high temperature peak) lines represent the deconvoluted curves for each P:L ratio.
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and LFampin265-284 alone do hardly interact with DMPC liposomes,
as revealed from DSC and CD, when bound together in LFchimera they
contribute to themixture of structures observed by CD for this peptide's
interaction with zwitterionic lipids.
In the presence of DMPC/DMPG (3:1), both LFampin265-284 and
LFchimera show the predominance of α-helix structure, with
well-deﬁned minima around 208 and 222 nm (Fig. 4b and c). Never-
theless the α-helix structure is better deﬁned in the case of
LFampin265-284. Finally LFcin17-30 shows CD spectra in this lipid
mixture that clearly reﬂects a mixture of α-helix and β-structure
(Fig. 4a). We should stress that in a previous paper we showed that
this peptide presents the structure of a β-turn in the presence of
purely negatively charged membranes of DMPG [16], and it is thus
reasonable that this structure already appears in the DMPC/DMPG
(3:1) lipid mixture, although to a smaller extent.
Overall, it is clear that the structure of the peptides changes in the
presence of membranes, and that the structure adopted depends on
the peptide and the lipid mixture.Fig. 4. CD spectra of (a) LFcin17-30, (b) LFampin265-284 and (c) LFchimera at 35 °C in:
buffer (peptide concentration 36 μM) (solid black); DMPC 6 mM (dash gray); and
DMPC/DMPG (3:1) 3 mM (dotted light gray). P:L ratio in peptide/LUV mixtures was
1:167.3.3. X-ray diffraction
Curiously, SAXD experiments revealed that each of the three stud-
ied peptides induces different structural changes in DMPC/DMPG
(3:1) membrane. The structural changes are temperature dependent,
and we present typical diffraction patterns at selected temperatures
with the aim to shed more light into the mechanism of peptide–
membrane interaction.
The SAXD and WAXD results obtained for LFcin17-30 and DMPC/
DMPG (3:1) at selected temperatures, for a P:L ratio 1:8 (mol/mol)
can be found in Fig. 5. Despite the high peptide to lipid molar ratio
in the sample, SAXD did not indicate the occurrence of membrane
disruption. As described in the Materials and methods section, prior
to interaction with the peptide the DMPC/DMPG (3:1) mixture
forms a dispersion of unilamellar (or oligolamellar) vesicles. Such dis-
persion does not have a long range order and SAX diffraction shows a
broad peak with intensity at the level of background (not shown). In
the gel phase, the phospholipid acyl chains are fully extended, packed
hexagonally and oriented more or less perpendicularly to the surface
of the bilayer, a structural feature documented by a peak in WAX dif-
fraction. For our pure DMPC/DMPG (3:1) mixture the temperature of
gel to liquid crystalline phase transition was found to be Tm=25 °C
by our DSC experiments (Table 3). The diffractogram obtained for
the mixture LFcin17-30 and DMPC/DMPG (3:1) taken at 10 °Ccorresponds well with the description above and shows no evidence
of interaction of the AMP with the DMPC/DMPG (3:1) membrane.
However, heating the system above the phase transition temperature
of the mixture, we observe a lamellar phase with a repeat distance d
slightly decreasing with increasing temperature — d=61.7 and
58.5 Å at 35 and 50 °C, respectively. The WAXD pattern, on the
other hand, exhibits wide diffuse scattering in the range ~0.18–
0.35 Å−1, characteristic for phospholipid liquid-like carbon chains
(Fig. 5). This indicates that the peptide has a better interaction with
the membrane in liquid crystalline resulting in structural changes
due to charge screening of both DMPC/DMPG membrane and
LFcin17-30. Cooling down the mixture, we identiﬁed two distinct
Fig. 5. SAXD (a) and WAXD (b) patterns for a peptide/lipid mixture of LFcin17-30 and DMPC/DMPG (3:1) for P:L=1:8 (mol/mol), at selected temperatures. The lipid concentration
was 12 mM.
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repeat distances dA=70.9 Å and dB=65.7 Å at 10 °C, an indication
that the cooling process leads to a non-homogeneous distribution of
the components in the system.
The other two peptides of the lactoferrin family show a more dis-
ruptive behavior against the DMPC/DPMG (3:1) membrane. Our
previously published X-ray diffraction study on the system with
LFampin265-284 and DMPC/DMPG (3:1) revealed the membrane dis-
integration through a micellar cubic phase of space group Pm3n [36].
By performing SAXD measurements at increasing temperatures we
observed that the cubic phase Pm3n occurs in a temperature range
where the pure DMPC/DMPG (3:1) mixture was still in the gel state.
Fig. 6 shows SAX diffractograms of mixtures of LFampin265-284
with DMPC/DMPG (3:1) at two P:L molar ratios (1:8 and 1:5) and se-
lected temperatures. At both P:L ratios and ~20 °C we observe a cubicFig. 6. SAX diffractograms for mixtures of LFampin265-284 with DMPC/DMPG (3:1) at
different temperatures and P:L molar ratios: (a) and (b): P:L=1:8; (c) and (d): P:L=
1:5. Intensities are plotted in logarithmic scale.phase of Pm3n space group (Fig. 6a, c). The lattice parameters depend
on P:L ratio, as the value obtained for a P:L ratio 1:5 was a=129.0±
0.1 Å, whereas for 1:8 we obtained a=119.4±0.1 Å, determined as
described in the Materials and methods section. The unit cell dimen-
sion of Pm3n cubic phase was also found to be dependent on temper-
ature, with the cell dimension slightly decreasing as the temperature
increased. The Pm3n phase is usually observed at high water content
and is supposed to consist of discrete micelles of amphiphiles ar-
ranged on a cubic lattice and separated by a continuous ﬁlm of water.
The phase transition accompanying the disappearance of the cubic
phase involves massive structural changes in the mixture, which in
SAX is reﬂected in a broad, not well resolved peak [36]. At higher tem-
peratures, we detected a lamellar Lα phase. The onset of the Lα phase
was found to depend on P:L molar ratio — for P:L=1:8 it was ob-
served at ~29 °C, whereas for P:L=1:5 the Lα phase was not detected
until ~60 °C. Bellow this temperature, diffractograms show 2–3 peaks
above a broad background as (Fig. 6), probably due to scattering
on partly ordered intermediated structures in the process of cubic
phase disappearance.
LFchimera was identiﬁed as the peptide with much stronger dis-
ruptive effect on the model membrane, as revealed by the DSC results
(Section 3.1, Fig. 2c and Table 3).
We examined its effect on the DMPC/DMPG (3:1) membrane at
several P:L molar ratios. At low molar ratio (P:L=1:38) the peptide
does not disrupt the membrane, but in the temperature range of
15–40 °C we observe a lamellar phase with periodicities 64.2 and
56.3 Å at 20 and 40 °C, respectively (not shown). This shows
that although the peptide initially interacts with unilamellar or
oligolamellar vesicles at low P:L ratio it has the ability to build a
multilamellar structure. At the same temperatures, we found
dDMPC=66.5 and 62.0 Å, where dDMPC is the repeat distance of
DMPC bilayer stacking. The observed lower spacing (~6 Å) at 40 °C
indicates that either the peptide mediates a closer approach between
two opposite charged bilayers due to membrane/AMP charge com-
pensation or the thickness of the membrane itself is reduced after
AMP intercalation. As we increase P:L ratio, SAX diffractograms al-
ready detected changes in the lamellar organization, but at tempera-
tures below Tm and for P:L=1:30 we only observe a not well resolved
phase of higher symmetry (not shown), that becomes better deﬁned
Fig. 7. SAX diffractograms of a heating scan between 15 and 40 °C for LFchimera and
DMPC/DMPG (3:1) at a P:L ratio 1:21.
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compatibility with the ﬂuid phase, as expected. Increasing the
LFchimera content to molar ratio P:L=1:21, the membrane was
disrupted and SAXD clearly conﬁrmed the presence of non-lamellar
phase(s) (Figs. 7 and 8). In Fig. 7 we show diffractograms of a heating
scan between 15 and 40 °C for this peptide with DMPC/DMPG (3:1)
at this later P:L ratio, where the peaks corresponding to a phase or
phases of higher symmetry are clearly seen.
Two representative diffractograms at 24 and 30 °C with respective
peak assignment are presented in Fig. 8. At low temperature, the
deconvolution of the diffraction pattern revealed the coexistence ofFig. 8. SAXD patterns for a peptide/lipid mixture of LFchimera and DMPC/DMPG (3:1) for
P:L=1:21 (mol/mol), at selected temperatures, 30 and 24 °C. Insert: a plot of s (Å−1) vs.
√(h2+k2+ l2) for all observed reﬂections at 24 °C.two cubic phases with reﬂections compatible with Pn3m and Im3m
space groups. The lattice parameters aPn3m=107.9±0.3 Å and
aIm3m=155.6±0.9 Å at 24 °C were determined as described in the
Material andmethods section, with R2=0.9999 and 0.9997, respective-
ly. The ratio of the unit cell parameters for the two cubic phases is aIm3m/
aPn3m ~1.4. On increasing temperature above ~25 °C both cubic phases
vanish and we observe two diffuse peaks with intensities decreasing
with temperature, and ﬁnally merging in the background (Figs. 7
and 8). Concurrently a lamellar phase is detected, with periodicity
d~56.5–54.9 Å in the range of 27–40 °C, thus decreasing as the temper-
ature increases.
4. Discussion
The determination of the structure of AMPs upon interaction with
membranes, together with the characterization of the changes ob-
served in the membrane structure as a result of this interaction, can
help to unravel the antimicrobial peptide's mechanism of action. In
the present study we address these two aspects through DSC, CD
and SAXD studies on model membranes, and compare themwith pre-
vious results of their effects on C. albicans (Table 1) [37,38]. The struc-
tural characterization derived from SAXD using model membranes
and from freeze-fracture with C. albicans allows a comparison of re-
sults derived from two widely different approaches, namely with
model and pathogen membranes.
The designed lactoferrin chimera and its constituent peptides
presented high candidacidal activity, as can be seen by the low values
of LC50 previously obtained [37,38] and provided in Table 1. Freeze-
fracture electron microscopy of the yeast showed that the peptides in-
duce different levels of membrane damage [37,38]. All peptides clearly
affected the membrane morphology of C. albicans, albeit differently
(Table 1). LFcin17-30 had theweakest effect on themembrane, altering
signiﬁcantly the distribution of the intra-membranous particles (IMP)
as compared to control, into IMP-free and IMP-dense areas, suggesting
possible IMP aggregation and/or lipid segregation (Table 1, b).
LFampin265–284 had a much stronger effect, indicating substantial
weakening of the cytoplasmic membrane, as evidenced by the appear-
ance of disruptions into vesicle-like structures (Table 1, c). Finally
LFchimera severely destroyed the membrane (Table 1, d).
Our DSC results showed that LFcin17-30 and LFampin265-284 do
not interact with the model membranes formed from zwitterionic
DMPC, whereas LFchimera does. Measurements performed with
DPPC liposomes and LFampin265-284 [48] as well as with similar
peptides, LFcin17-41 [49], LFcin17-31 [21] and LFampin268-284
[17] also show that the thermotropic proﬁle of the liposomes is not
affected by the presence of the peptides, up to a P:L ratio of 1:10.
All these results indicate that LFcin and LFampin peptides do not sig-
niﬁcantly alter the structural organization of bilayers of zwitterionic
lipids. It is interesting to note that LFchimera is the result of a special
link between LFcin17-30 and LFampin265-284 through an additional
lysine [16], and it shows signiﬁcant interaction with DMPC liposomes,
at odds with the constituent peptides. This synergism has been ob-
served for this peptide [16,18,37,50,51], and probably reﬂects its
very high charge (+12), that along with its amphipatic structure
leads to the partition to zwitterionic membranes. In line with the crit-
ical importance of charge in AMP/membrane interaction, a strong
correlation was recently found between the net positive charge of
peptides and their capacity to induce anionic lipid clustering, which
was found to be independent of their secondary structure [52]. Over-
all, the obtained results of the interaction of these peptides with zwit-
terionic membranes are in agreement with the non-hemolytic
behavior of LFcin17-30 and LFampin265-284, and the mild hemolytic
character of LFchimera [51,53,54].
All three peptides change their secondary structure upon interaction
with the membranes, as long as the membrane has signiﬁcant negative
charge (25% in our case), as shown by the CD results. Only in the case of
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membranes is observed, in line with the DSC results. Again this effect
might follow from a high charge and amphipaticity, with a mixture of
secondary structures that would maximize the electrostatic and hydro-
phobic interactions.
In the present work we observed the predominance of α-helix
structure upon interaction with DMPC/DMPG membranes for
LFampin265-284 and LFchimera. The presence of signiﬁcant amounts
of α-helix was also found for LFampin268-284 [17] and LFampin265-
284 [18,48] in the presence of SDSmicelles. Strøm et al. [55] have stud-
ied LFcin17-31, and they obtained a percentage of helicity of only 4% for
this peptide in contactwith SDS, indicating that in the presence of purely
negative micelles this peptide does hardly adopts a helical structure.
Haney et al. [18] have studied these three peptides, LFcin17-30,
LFampin265-284 and LFchimera by a variety of techniques, but their
CD results are also obtained in the presence of SDS micelles. Again,
they found that for LFcin17-30 the intensity of the negative peaks char-
acteristic of α-helix structure is fairly weak, whereas for LFampin265-
284 and LFchimera strong negative minima are present. These results
are in linewith the ones reported here for DMPC/DMPG (3:1) liposomes,
as well as with our previous results in the presence of DMPG [16].
The biological importance of cubic phases was addressed in the
seminal work of Luzatti and collaborators [32]. In recent years, Lohner
et al. addressed this issue by X-ray scattering in the context of AMPs
[12], and the presence of cubic phases upon AMP interaction is now
documented both with simple model membranes [19,36,56] as well
as with lipid extracts from pathogenic agents [26,27]. Further, their
importance has been stressed in recent reviews [1,23,28]. The induc-
tion of cubic phases by AMPs, mostly by lowering the lamellar to
non-lamellar phase boundary of lipid membranes, could indicate
that the peptides act by promoting an extensive bilayer curvature,
leading eventually to either the formation of pores, mainly of the to-
roidal type [28] or even to membrane disruption (micellization). The
formation of non-lamellar phases could also alter lipid domains in the
cellular membrane that are important for many biological processes
such endocytosis, or even the activity of membrane proteins that
most of the time depend on these domains, culminating into impair-
ment of the membrane function [33,34]. Most reported work so far
points to the induction of cubic phases, mostly of Pn3m and Im3m
symmetry, as we have found for LFchimera. In the present report it
was very interesting to ﬁnd that three peptides from the same family,
lactoferrin, have quite different effects on membranes of the same
composition. LFcin17-30 only induces segregation of the lipid moiety,
and leads to the formation of two lamellar phases in the gel phase, on
cooling, with repeat distances dA=70.9 Å and dB=65.7 Å at 10 °C. At
this temperature, neutral DMPC itself forms a gel lamellar phase with
the repeat distance of ~60.1 Å. This value is comparable with the pe-
riodicity of LB phase dB=65.7 Å indicating thus the domain with less
AMP. Lowering the temperature beyond Tm may affect differently the
mobility of individual membrane's components, which together with
the tendency for effective charge compensation results in a segrega-
tion of the membrane components. For systems polyelectrolyte–cat-
ionic membrane it was suggested that the presence of negatively
charged DNA between bilayers can induce a partial lateral segregation
of cationic surfactants to minimize the electrostatic energy of the
whole system, i.e., lateral “demixing” in the plane of the bilayer can
occur [57]. It has been proven experimentally that the polyelectrolyte-
bound population is enriched with oppositely charged lipid, while the
polyelectrolyte-free lipid population is correspondingly depleted
[58,59]. These observations correlate very well with the membrane
lipid segregation observed by freeze-fracture, and consequent protein
reorganization.
LFcin17-30 was found to be the peptide among the three studied
here with lowest membrane activity against C. albicans. It is indeed
remarkable that our SAX results indicate that for LFcin17-30, only a
segregation effect on the lipid mixture takes place, as revealed bythe appearance of two lamellar phases upon cooling, and the peptide
does not induce a cubic phase. This peptide's mild effect on the mem-
brane also agrees with previous reports of internal targets for LFcin
peptides [8–11], as well as with the slower kinetics observed against
Leishmania [50]. All these results lead us to propose that peptides that
only induce a mild membrane effect, like LFcin17-30, as observed by
SAXD (segregation) are likely to have internal targets as part of
their mode of action, as long as they are known to be active.
LFampin265-284 induces amicellar cubic phase of Pm3n type on the
model membranes of DMPC/DMPG, compatible with a detergent-like
action that would cause plasma membrane solubilization [36]. The
DSC results obtained for DMPC/DMPG (3:1) and LFampin265-284 at
high peptide contents (Fig. 3) allowed us to shed some light in the ob-
served lipid/peptide cubic organization for the mixture. Overall we
can see that a transition is still observed by DSC in a temperature
range where we already observe the presence of a cubic phase by
SAX. As it is known that the transition to cubic phase is a low energy
one, thus not easily detectable by DSC [60], the peaks observed must
be related to a transition between gel and liquid crystalline phases.
This transition is compatible with the peak we observe in WAX at
20 °C (not shown) indicative of the presence of gel phase. Further, it
can account for what we previously hypothesized [36], i.e., that not all
lipids are involved in the cubic phase and that the volume fraction of
non-lamellar phase depends on temperature and P:L ratio. Thus the re-
sults frombothmethods taken together show that the cubic phasemust
coexist with a lamellar phase, whose presence is reﬂected in SAX
diffractograms in the high background observed for both 1:5 and 1:8
P:L mixtures. Further, by DSC we see that above 30 °C the mixture is
completely in liquid crystalline state, which is compatible with the ob-
served peaks of an organized lamellar phase whose onset we see by
SAX at 29 °C [36] for the 1:8mixture. For themixturewith high peptide
content (1:5) the lamellar phase only appears at high temperature,
probably because the volume fraction involved in the cubic phase is
higher at this peptide content.
As mentioned before in the results' section, two peaks are clearly
seen in DSC, thus the mixture is not homogeneous. The ﬁrst appears
at a temperature lower than Tm of the pure lipid mixture, leading to
the onset of gel to liquid crystalline transition at ~22.6 °C. This de-
creased stability should facilitate the transition to a cubic arrange-
ment, and in fact we could see by SAXD that for the mixture 1:8 the
onset of cubic phase appearance could be observed already at
~22 °C. The DSC tracing also shows a very broad transition (between
~20 and 32 °C), in a temperature range that coincides with the
presence of cubic phase. Thus from ~20 °C there is a fraction of the
peptide/lipid membrane that starts to have a transition to liquid crys-
talline state and subsequently can undergo a transition to cubic phase
in this temperature range, whereas the remaining fraction is still in
the gel phase until ~26 °C. This last fraction shows a very broad,
non-cooperative transition that could be responsible for the observed
high background in the diffractograms in this temperature range. At
temperatures above the disappearance of the cubic phase a massive
system reorganization takes place, as pointed out before [36]. The ob-
servation of Lα at high temperatures can seem surprising, as micellar
phase Pm3n is commonly known to change either to a micellar solu-
tion or to a hexagonal phase. It must be stressed that we do not sug-
gest that the origin of the Lα phase at high temperature is a transition
from the cubic Pm3n phase. As the temperature is raised, the cubic
phase vanishes and a redistribution of charged AMP induces massive
structural changes. Further, as we suggested earlier [36] and our DSC
results here conﬁrm, part of the lipid mixture is not involved in the
cubic phase. We found a repeat distance d=65.9 Å of Lα phase at
50 °C (P:L=1:8), and DMPC multilamellar vesicles show at this tem-
perature a repeat distance of 60.7 Å. The higher spacing observed as
compared to pure DMPC can be accounted for either to the presence
of the peptide between the lipid bilayers or as due to a residual charge
imbalance in the system.
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SAXD, aside from being the ﬁrst reported micellar cubic phase in the
context of antimicrobial/peptide membrane interactions, is a result
that parallels the ﬁndings by freeze-fracture for LFampin265-284
when in contactwith C. albicans, showing again a remarkable agreement
between the results with model and actual pathogens' membranes.
SAXD results for LFchimera show the presence of cubic phase, and
for the P:L ratio 1:21 the coexistence of two cubic phases (Pn3m and
Im3m) was clearly resolved. The ratio obtained of the unit cell param-
eters for the two cubic phases was aIm3m/aPn3m ~1.4, showing a signif-
icant deviation from the ideal Bonnet relation 1.28, for coexisting
cubic phases related to the minimal surfaces for a system in thermo-
dynamic equilibrium [61,62]. For AMPs/model membranes, epitaxial
relationships between coexisting cubic phases and hexagonal or
lamellar phases were reported previously [19,23,26,27,63]. The tran-
sitions from liquid crystalline lamellar to cubic phase as well as with-
in different cubic phases occur in a narrow range, and coexistence of
phases has been reported, as well as hysteresis. Therefore the system
might not have been able to reach thermodynamic equilibrium, and
that could justify the deviation of the ratio of lattice parameters
from the ideal Bonnet relation. Further, the Bonnet transformation
is derived from a mathematical treatment of coexisting inﬁnite
minimal surfaces (IMS), and relates the primitive and diamond (and
gyroid) surfaces via intermediate self-interacting minimal surfaces,
and real systems can deviate from this theoretical prediction, either
because they do not conform to it or because the system is not at
equilibrium [63]. As the temperature increases above the range of
cubic phase stability the lipid network is disrupted. Some released
lipid/AMP fragments can initially keep some symmetry in their orga-
nization, which in SAXD is observed as two diffuse peaks. With
heating, their volume fraction in the sample decreases as documented
by the observed decrease in the intensity of the diffuse peaks, while
simultaneously we observe the increase in the intensity of peaks re-
lated to a lamellar phase. The released lipid or lipid/AMP fragments
are reorganized into the lamellar phase to decrease the free energy
of the whole system. The retrieved periodicity of the lamellar phase
(d~54.9 Å at 40 °C) is smaller than for DMPC membrane at the
same temperature (dDMPC~62.0 Å), and closer to the periodicity
(d~56.3 Å at 40 °C) derived from our system at low P:L molar ratio
where DMPC/DMPG membrane was not disrupted (P:L=1:38). At
molar ratio P:L=1:30 SAXD detected the membrane disruption by
LFchimera (see Results section). Thus our experiments indicate the
value ~1:34(±4) as a critical for the DMPC/DMPG (3:1) membrane
disruption by LFchimera.
Finally we would like to point out that the formation of two cubic
phases, of symmetry Pn3m and Im3m, would lead to total membrane
disruption, in a way that parallels what was observed by freeze-
fracture. It should be noted that Bolscher et al. [37] refer the presence
of some vesicular structures as observed in freeze-fracture experi-
ments also in the case of LFchimera, together with a massive mem-
brane disruption. This peptide is very complex, both due to its
extremely high positive charge as well as to its unusual link of con-
stituent peptides through a lysine side chain. In our SAXD experi-
ments with the simple model system of DMPC/DMPG (3:1) we
could only assign the presence of two cubic phases, Pn3m and
Im3m. Nevertheless, the possibility of other structures to be formed
upon interaction with the more complex membrane of C. albicans
cannot be discarded.
Thus, overall we could ﬁnd a remarkable match between the effect
of these peptides on C. albicans membrane as observed by freeze-
fracture and the structural features they revealed in a simple model
membrane system particularly suited to mimic C. albicans (known
to have a signiﬁcant PC content). This has several important conse-
quences: i) it indicates that structural studies involving simple
model membranes can provide very important information as regard-
ing different modes of action of AMPs; and ii) the conclusions that canbe drawn are indeed much more sound when accompanied by mea-
surements involving real pathogens.
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